Telemedicine as effective as in-person care for Parkinson's disease

August 16, 2017

New findings from a nationwide program that links neurologists with patients with Parkinson's disease in their homes via video conferencing shows that telemedicine can successfully deliver quality care. The study, which appears today in the journal Neurology, points to a new way to improve care for people who suffer from the disease, but may have not have access to a neurologist.

"Virtual house calls for chronic diseases like Parkinson's are not only as effective as in-person care but broader adoption of this technology has the potential to expand access to patient-centered care," said Ray Dorsey, M.D., the David M. Levy Professor of Neurology at the University of Rochester Medical Center (URMC) and lead author of the study. "We now have the ability to reach anyone, anywhere but the promise and benefits of telemedicine will not be fully realized until the changes are made in Medicare policy."

"Telemedicine is especially valuable to patients in remote, rural, and underserved areas because it gives them the ability to consult specialists they would otherwise have to travel hours to see," said Peter Schmidt, Ph.D., Senior Vice President, Chief Research and Clinical Officer of the Parkinson's Foundation. "The Parkinson's Foundation aims to narrow these gaps in Parkinson's care, which is why we are working with experts from URMC, a Parkinson's Foundation Center of Excellence."

The results in the paper come from the Connect.Parkinson project, a research study funded by the federal Patient-Centered Outcome Research Institute. Connect.Parkinson is led by URMC in collaboration with the Parkinson's Foundation and with additional support from PatientsLikeMe, the Michael J. Fox Foundation for Parkinson's Research, SBR Health, Vidyo, and IDSolutions. The study is the first national randomized controlled clinical trial of telemedicine for Parkinson's .

It is estimated that 40 percent of people who have Parkinson's disease do not see a neurologist soon after diagnosis. This places them at significantly greater risk of falls leading to hip fractures, ending up in a nursing home or hospital, and even death. This challenge of providing care to these individuals will become ever greater as the population ages—it is projected that the number of people with Parkinson's disease will double by 2030.

The most significant barriers to appropriate care for Parkinson's patients are distance and disability. Most movement disorder specialists are located in in large urban areas. Most patients live in suburban and rural areas, have impaired mobility and driving ability, and are faced with the challenge of making frequent trips to the doctor's office - a task that becomes more difficult as the disease progresses.

The goal of the Connect.Parkinson study was to see if telemedicine would allow neurologists to deliver care to patients in the comfort of their homes. A total of 195 individuals with Parkinson's from across the U.S. were selected to participate in the study. Participants either received care through their or had that care supplemented with up to four visits via video conference with the neurologist they had not seen before.

Parkinson's disease particularly lends itself to telemedicine because many aspects of the diagnosis and treatment of the disease are "visual" - meaning that the interaction with the doctor primarily consists of listening to the patient and observing them perform certain tasks such as holding their hands out or walking.

The researchers found that the telemedicine visits were as effective as in-person visits in the doctor's office, with the quality of life reported by the participants as no better or worse for people who received care in their homes compared with those who received standard care. The virtual house calls also saved patients an average of 169 minutes and nearly 100 miles of travel per visit.

While the current study is one of several that have demonstrated the potential benefits of telemedicine, widespread adoption of this technology is hindered by federal healthcare policies. Approximately two-thirds of Parkinson's patients are on Medicare. However, the program does not reimburse for in-home telemedicine care. Legislation has been introduced in Congress to allow Medicare to expand reimbursement for .

"We can shop, bank, make travel reservations, take classes, and buy groceries via the internet from the comfort of our own homes, but too many patients still cannot access health care," said Dorsey. "Telemedicine is an option if you are a veteran, a member of the Armed Services, a Medicaid beneficiary, or a Canadian, but not if you have a chronic condition and are a Medicare beneficiary."

Explore further: Telemedicine brings Parkinson's care to 'anyone, anywhere'

Related Stories

Telemedicine brings Parkinson's care to 'anyone, anywhere'

December 4, 2013
A new study shows that a neurologist in an office thousands of miles away can deliver effective specialized care to people with Parkinson's disease. For individuals with the condition – many of whom have never seen a specialist ...

Telemedicine use increases among rural Medicare beneficiaries

May 10, 2016
The use of telemedicine is increasing rapidly.

'Virtual' house calls comparable to in-person care for people with Parkinson's disease, study finds

March 11, 2013
A small study of 20 people with Parkinson's disease suggests that "virtual house calls" using Web-based video conferencing provide clinical benefits comparable to in-person physician office visits, while saving patients and ...

The doctor will (virtually) see you now

June 8, 2017
(HealthDay)—Telemedicine is playing an ever-expanding role in the U.S. health care landscape.

Use of telemedicine for mental health in rural areas on the rise but uneven

May 1, 2017
Newly published research by Harvard Medical School and the RAND Corporation reveals a dramatic growth in the use of telemedicine for the diagnosis and treatment of mental health disorders in rural areas, but strikingly uneven ...

Recommended for you

Genetic defects in the cell's 'waste disposal system' linked to Parkinson's disease

November 14, 2017
An international study has shed new light on the genetic factors associated with Parkinson's disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of ...

Parkinson's disease: A looming pandemic

November 13, 2017
New research shows that the number of people with Parkinson's disease will soon grow to pandemic proportions. In a commentary appearing today in the journal JAMA Neurology, University of Rochester Medical Center neurologist ...

Focused ultrasound shows promise for treating Parkinson's tremor

October 30, 2017
An initial test to determine if a scalpel-free form of brain surgery can reduce tremor caused by Parkinson's disease has produced encouraging results. Further research is warranted, the researchers conclude in a paper published ...

Novel technique explains herbicide's link to Parkinson's disease

October 23, 2017
Northwestern Medicine scientists have used an innovative gene editing technique to identify the genes that may lead to Parkinson's disease after exposure to paraquat, a commonly-used herbicide.

Data, technology drive new approaches to Parkinson's care

October 23, 2017
Complex, multi-system diseases like Parkinson's have long posed challenges to both scientists and physicians. University of Rochester Medical Center (URMC) researchers are now reaching for new tools, such as algorithms, ...

Investigating the most common genetic contributor to Parkinson's disease

October 19, 2017
LRRK2 gene mutations are the most common genetic cause of Parkinson's disease (PD), but the normal physiological role of this gene in the brain remains unclear. In a paper published in Neuron, Brigham and Women's Hospital ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.